KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Net Income (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Net Income for 13 consecutive years, with -$7.8 million as the latest value for Q4 2025.

  • Quarterly Net Income fell 44.56% to -$7.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$25.5 million through Dec 2025, down 35.03% year-over-year, with the annual reading at -$25.5 million for FY2025, 35.03% down from the prior year.
  • Net Income hit -$7.8 million in Q4 2025 for ClearPoint Neuro, down from -$5.9 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$2.5 million in Q1 2021 to a low of -$7.8 million in Q4 2025.
  • Historically, Net Income has averaged -$4.9 million across 5 years, with a median of -$4.6 million in 2022.
  • Biggest five-year swings in Net Income: tumbled 174.41% in 2021 and later soared 38.19% in 2024.
  • Year by year, Net Income stood at -$4.1 million in 2021, then dropped by 7.79% to -$4.5 million in 2022, then fell by 5.3% to -$4.7 million in 2023, then fell by 14.45% to -$5.4 million in 2024, then crashed by 44.56% to -$7.8 million in 2025.
  • Business Quant data shows Net Income for CLPT at -$7.8 million in Q4 2025, -$5.9 million in Q3 2025, and -$5.8 million in Q2 2025.